JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathiesGina A. Montealegre Sanchez, Jonathan Janes, Philip J. Hashkes et al.|Journal of Clinical Investigation|2018Cited by 519
OTULIN deficiency in ORAS causes cell type‐specific LUBAC degradation, dysregulated TNF signalling and cell deathRune Busk Damgaard, Yackov Berkun|EMBO Molecular Medicine|2019Cited by 118